We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Wireless Vital Signs Monitoring System

By HospiMedica staff writers
Posted on 22 Oct 2004
A new system for measuring vital signs can telemetrically monitor physiologic parameters without wires or probes. More...


Called VitalSense, the system was developed by the Mini Mitter Company (Bend, OR, USA) in collaboration with the U.S. Army Research Institute of Environmental Medicine (Natick, MA, USA). Phase 1 of the system includes sensors for core body and skin temperature. Phase 2, a heart-rate sensor, is scheduled for release in late 2004. Sensors to monitor other physiologic parameters are also under development. Vital Sense was initially used to monitor U.S. Army Rangers and has been cleared by the U.S. Food and Drug Administration (FDA).

Core body temperatures are obtained from ingestible and disposable core body temperature sensors contained in a capsule about the size of a multivitamin. Once activated and swallowed, transmission of data from the capsule begins immediately. Data are transmitted telemetrically to the VitalSense monitor, which can be worn in a waist pack or slipped into a pocket. The mean transit time for the capsule is 0.5-3.5 days. Dermal temperatures are transmitted from waterproof, hypoallergenic patches. Transmission range is about one meter for the ingestible sensor and two meters for the patches.

In normal mode, the monitor can track and record data from up to 10 sensors that are associated with the monitor, while rejecting signals from other sensors that may be within range. Applications include ovulation detection and sepsis detection in hospitals. The company believes the system also has applications in telemedicine.





Related Links:
Mini Mitter Co.
U.S. Army Research Inst.

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.